Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 63187-726

2 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 63187-726). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bupropion Hydrochloride Sr 1)

Chemical Structure (Bupropion Hydrochloride Sr 1)
Chemical structure diagram of bupropion hydrochloride showing a chlorophenyl ring, a ketone group, and a tertiary amine with three methyl groups, illustrating the molecular structure of the active ingredient.*
FDA Label Image

63187-726-30 (Bupropion Hydrochloride Sr 3)

63187-726-30 (Bupropion Hydrochloride Sr 3)
Label for Bupropion Hydrochloride SR 150 mg Extended-Release Tablets by Proficient Rx LP. The bottle label indicates a quantity of 30 tablets and includes dosage instructions to take twice daily. It features barcode, NDC 63187-726-30, and manufacturer details as Actavis Laboratories FL, Inc. Storage instructions specify 20°-25°C (68°-77°F). Additional warnings state not to use with ZYBAN or other bupropion hydrochloride-containing medications.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.